MX2023014679A - Peptidos grapados y metodos para su obtencion. - Google Patents
Peptidos grapados y metodos para su obtencion.Info
- Publication number
- MX2023014679A MX2023014679A MX2023014679A MX2023014679A MX2023014679A MX 2023014679 A MX2023014679 A MX 2023014679A MX 2023014679 A MX2023014679 A MX 2023014679A MX 2023014679 A MX2023014679 A MX 2023014679A MX 2023014679 A MX2023014679 A MX 2023014679A
- Authority
- MX
- Mexico
- Prior art keywords
- present disclosure
- disclosure provides
- catenin
- beta
- agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208487P | 2021-06-08 | 2021-06-08 | |
| US202163224834P | 2021-07-22 | 2021-07-22 | |
| US202263303952P | 2022-01-27 | 2022-01-27 | |
| PCT/US2022/032738 WO2022261257A1 (en) | 2021-06-08 | 2022-06-08 | Stapled peptides and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023014679A true MX2023014679A (es) | 2024-01-15 |
Family
ID=84425507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023014679A MX2023014679A (es) | 2021-06-08 | 2022-06-08 | Peptidos grapados y metodos para su obtencion. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240360179A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4355350A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024522368A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240031957A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023025528A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3218824A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL308790A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023014679A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022261257A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020004555A2 (pt) | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| AU2019326423A1 (en) | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| US20260207704A1 (en) * | 2022-12-15 | 2026-07-23 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
| WO2024130217A1 (en) * | 2022-12-15 | 2024-06-20 | Fog Pharmaceuticals, Inc. | Stapled peptides and methods thereof |
| WO2024130224A2 (en) * | 2022-12-16 | 2024-06-20 | Purdue Research Foundation | Stapled peptides for sensitization of cancer to treatment |
| JP2026520144A (ja) * | 2023-06-06 | 2026-06-22 | パラビリス メディシンズ, インコーポレイテッド | ステープルペプチドおよびその方法 |
| WO2025265097A1 (en) * | 2024-06-20 | 2025-12-26 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508531B1 (en) * | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP3549951A3 (en) * | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| EP3782638A1 (en) * | 2013-03-13 | 2021-02-24 | President and Fellows of Harvard College | Stapled and stitched polypeptides and uses thereof |
| WO2016085280A1 (ko) * | 2014-11-28 | 2016-06-02 | 서울대학교산학협력단 | 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도 |
| US10011631B2 (en) * | 2015-12-01 | 2018-07-03 | The University Of Hong Kong | Stapled helical peptides and methods of synthesis |
| BR112020004555A2 (pt) * | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| CN111447941B (zh) * | 2017-10-27 | 2023-10-31 | 俄亥俄州国家创新基金会 | 用于细胞内递送装订肽的多肽缀合物 |
| AU2019326423A1 (en) * | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| CA3186681A1 (en) * | 2020-07-22 | 2022-01-27 | Brian Halbert WHITE | Stapled peptides and methods thereof |
-
2022
- 2022-06-08 BR BR112023025528A patent/BR112023025528A2/pt unknown
- 2022-06-08 EP EP22820994.6A patent/EP4355350A4/en active Pending
- 2022-06-08 CA CA3218824A patent/CA3218824A1/en active Pending
- 2022-06-08 MX MX2023014679A patent/MX2023014679A/es unknown
- 2022-06-08 WO PCT/US2022/032738 patent/WO2022261257A1/en not_active Ceased
- 2022-06-08 JP JP2023575560A patent/JP2024522368A/ja active Pending
- 2022-06-08 KR KR1020237042998A patent/KR20240031957A/ko active Pending
- 2022-06-08 US US18/568,212 patent/US20240360179A1/en active Pending
- 2022-06-08 IL IL308790A patent/IL308790A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL308790A (en) | 2024-01-01 |
| JP2024522368A (ja) | 2024-06-18 |
| US20240360179A1 (en) | 2024-10-31 |
| BR112023025528A2 (pt) | 2024-02-27 |
| EP4355350A4 (en) | 2025-10-01 |
| WO2022261257A1 (en) | 2022-12-15 |
| EP4355350A1 (en) | 2024-04-24 |
| CA3218824A1 (en) | 2022-12-15 |
| KR20240031957A (ko) | 2024-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112023025528A2 (pt) | Peptídeos grampeados e métodos destes | |
| DOP2025000112A (es) | Compuestos moduladores de glp-1r | |
| CO2021007993A2 (es) | Compuestos de 2‐formil‐3‐hidroxifeniloximetilo capaces de modular la hemoglobina | |
| UY38685A (es) | Moduladores de la vía de tensión integrada | |
| CL2019002542A1 (es) | Nuevas moléculas de unión a antígeno biespecíficas capaces de unirse específicamente a cd40 y a fap. | |
| MX2023000947A (es) | Peptidos grapados y metodos para su obtencion. | |
| ECSP21026021A (es) | Moduladores de la expresión de pnpla3 | |
| CL2023002907A1 (es) | Anticuerpos anti-nectina-4 y usos de los mismos | |
| GT200900264A (es) | Moléculas y métodos para modular la pro-proteina | |
| AR071510A1 (es) | Anticuerpos anti- factor d humanizados y sus usos | |
| PE20140673A1 (es) | Nuevos moduladores y metodos para su uso | |
| CO2023015915A2 (es) | Anticuerpos anti-ccr8 | |
| CL2020003008A1 (es) | Estimulador de treg selectivo rur20kd-il-2 y composiciones relacionadas | |
| BR112021021645A2 (pt) | Anticorpos anti-hvem e uso dos mesmos. | |
| CO2023007768A2 (es) | Moléculas bifuncionales novedosas para la degradación de proteínas dirigidas | |
| CL2020001851A1 (es) | Moduladores de la expresión dnm2 | |
| BR112019003816A2 (pt) | composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição | |
| CL2022001130A1 (es) | Moléculas de fusión del ecd de siglec-9 y métodos de uso de estas | |
| AR048135A1 (es) | Uso de gen de amiloide a serico en el diagnostico y tratamiento del glaucoma y en la identificacion de agentes anti-glaucoma. | |
| CL2021001246A1 (es) | Moduladores de expresión irf5. | |
| DOP2018000218A (es) | Inhibidor de esterasa c1 conjugado y sus usos | |
| MX2021001943A (es) | Colecciones de péptidos, agentes peptídicos y métodos de uso de los mismos. | |
| MX2024000355A (es) | Inhibidores y usos de los mismos. | |
| CO2022003324A2 (es) | Anticuerpos anti-nrp1a y sus usos para tratar enfermedades oculares | |
| MX2022010958A (es) | Moleculas procesadas por la proteasa. |